Recruiting

Oncology Program

Sponsor:

NYU Langone Health

Code:

NCT06559059

Conditions

Lung Cancer Diagnosis

Colorectal Cancer (Diagnosis)

Prostate Cancer Diagnosis

Breast Cancer Diagnosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

National TeleOncology

Study Details

Brief summary:

The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.

Conditions

Lung Cancer Diagnosis

Colorectal Cancer (Diagnosis)

Prostate Cancer Diagnosis

Breast Cancer Diagnosis

Study ID

NCT06559059

Start date

Jun 18, 2024

Status verified date

Jun, 2026

Completion date

Jul 31, 2027

Anticipated

Primary completion date

May 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Patients Inclusion Criteria:

1. A Veteran
2. Aged 18 years or older
3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.

VAMC Providers and Staff Inclusion Criteria:

1. Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans
2. Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location

Patients Exclusion Criteria:

1. Veterans who have not seen any providers in the VA within the past year
2. Patients previously diagnosed with lung, prostate, breast, or colon cancer
3. Pregnant patients

VAMC Providers and Staff Exclusion Criteria:

1\. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA

Study Design

Enrollment

1800 participants

Anticipated

Allocation

Non randomized

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: VA National TeleOncology Service (NTO)

This arm will include

1. Veterans with a new cancer diagnosis of the lung, prostate, breast, or colon and a telehealth visit utilizing the VA National TeleOncology Service (NTO), and
2. VA health care providers and staff members participating in cancer care at NTO program medical centers.

no intervention: Usual Care

This arm will include

1. Veterans with a new cancer diagnosis of the lung, prostate, breast, or colon and a visit at a VA medical center location that has not implemented NTO, and
2. VA health care providers and staff members participating in cancer care at a medical center where the NTO program has not been implemented.

Interventions

National TeleOncology

Medical and/or subspecialty oncology care offered via facility-to-facility telehealth as an alternative to usual in-person care at the nearest VA or community oncology care setting offering similar services.

Primary outcome measure

  • Number of raw telehealth visits [ Time Frame: Post-NTO implementation (up to 3 months) ]
  • Fraction of patients engaging in at least one telehealth visit [ Time Frame: Post-NTO implementation (up to 3 months) ]

Central Contacts and Locations

Locations

VA New York Harbor Healthcare System - Brooklyn

Recruiting

Brooklyn, New York, United States, 11209

VA New York Harbor Healthcare System - St. Albans Community Living Center

Recruiting

Jamaica, New York, United States, 11425

VA New York Harbor Health Care System - Manhattan

Recruiting

New York, New York, United States, 10010

VA New York Harbor Healthcare System - Harlem Community Center

Recruiting

New York, New York, United States, 10027

VA New York Harbor Healthcare System - Staten Island Community Clinic

Recruiting

Staten Island, New York, United States, 10314

More Information

Sponsor

NYU Langone Health

Last update posted

Jun 3, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2026-06-03.